Recruiting Multiple Myeloma Studies in Lansing
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
The main objective of the trial is to assess the efficacy and safety of trimodulin as adjunctive treatment to standard of care (SoC) compared to placebo plus SoC in adult hospitalized subjects with sC...
Iberdomide and Daratumumab As Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
The goal of this phase 2 clinical trial is to learn if patients with Multiple Myeloma who are minimal residual disease positive after initial therapy (including an autologous stem cell transplant \[AS...
About Multiple Myeloma Clinical Trials in Lansing
Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.
There are currently 2 multiple myeloma clinical trials recruiting participants in Lansing, MI. These studies are seeking a combined 650 participants. Research is being sponsored by Biotest, Barbara Ann Karmanos Cancer Institute. Clinical trial participation is free and participants receive study-related medical care at no cost.
Multiple Myeloma Clinical Trials in Lansing — FAQ
Are there multiple myeloma clinical trials in Lansing?
Yes, there are 2 multiple myeloma clinical trials currently recruiting in Lansing, MI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Lansing?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lansing research site will contact you about next steps.
Are clinical trials in Lansing free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lansing studies also compensate for your time and travel.
What multiple myeloma treatments are being tested?
The 2 active trials in Lansing are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.
Data updated March 2, 2026 from ClinicalTrials.gov